î
îž
î
Phibro Animal Health Corp
PAHC40.060USD
+0.190+0.48%
āļāļīāļÂ 01/15, 16:00ïžETïžāļĢāļēāļāļēāļĨāđāļēāļāđāļē 15 āļāļēāļāļĩ
1.62BāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
23.94P/E TTM
î
āļĢāļēāļĒāļĨāļ°āđāļāļĩāļĒāļāđāļāļīāđāļĄāđāļāļīāļĄāļāļāļ Phibro Animal Health Corp āļāļĢāļīāļĐāļąāļ
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
āļāđāļāļĄāļđāļĨ Phibro Animal Health Corp
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPAHC
āļāļ·āđāļāļāļĢāļīāļĐāļąāļPhibro Animal Health Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 11, 2014
āļāļĩāļāļĩāđāļBendheim (Jack C)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ2475
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļApr 11
āļāļĩāđāļāļĒāļđāđGlenpointe Centre East, 3Rd Floor
āđāļĄāļ·āļāļTEANECK
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ07666
āđāļāļĢāļĻāļąāļāļāđ12013297300
āđāļ§āđāļāđāļāļāđhttps://www.pahc.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPAHC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 11, 2014
āļāļĩāļāļĩāđāļBendheim (Jack C)
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ Phibro Animal Health Corp
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
āļŠāļąāļāļŠāđāļ§āļāļāļāļāļĢāļēāļĒāđāļāđ
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļēāļĢāļāļĩāđ 6 āļĄ.āļ.
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļēāļĢāļāļĩāđ 6 āļĄ.āļ.
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
United States
202.35M
55.61%
Latin America and Canada
87.23M
23.97%
Europe & Middle East & Africa
44.94M
12.35%
Asia Pacific
29.38M
8.07%
āļāļēāļĄāļāļļāļĢāļāļīāļ
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļ
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
āļŠāļāļīāļāļīāļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļēāļĢāļāļĩāđ 18 āļ.āļĒ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļēāļĢāļāļĩāđ 18 āļ.āļĒ.
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
āļāļ·āđāļ āđ
67.35%
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
āļāļ·āđāļ āđ
67.35%
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
Investment Advisor
55.65%
Investment Advisor/Hedge Fund
29.60%
Hedge Fund
8.81%
Research Firm
3.30%
Pension Fund
1.72%
Individual Investor
0.52%
Bank and Trust
0.46%
Corporation
0.19%
Sovereign Wealth Fund
0.05%
āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļĪāļŦāļąāļŠāļāļĩāđ 1 āļĄ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļĪāļŦāļąāļŠāļāļĩāđ 1 āļĄ.āļ.
āļāđāļ§āļāđāļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļāļēāļ
āļāļģāļāļ§āļāļŠāļāļēāļāļąāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
2025Q4
421
20.39M
99.73%
-3.12M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļīāļāļāļĢāļĢāļĄāļāļđāđāļāļ·āļāļŦāļļāđāļ
îāļāļ·āđāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
āđāļāļĨāļĩāđāļĒāļ%
āļ§āļąāļāļāļĩāđ
BlackRock Institutional Trust Company, N.A.
2.92M
14.28%
-23.05K
-0.78%
Sep 30, 2025
The Vanguard Group, Inc.
1.52M
7.44%
-22.54K
-1.46%
Sep 30, 2025
State Street Investment Management (US)
894.04K
4.37%
-15.29K
-1.68%
Sep 30, 2025
Acadian Asset Management LLC
785.82K
3.84%
+61.38K
+8.47%
Sep 30, 2025
Renaissance Technologies LLC
555.20K
2.72%
-55.60K
-9.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
547.16K
2.68%
-7.77K
-1.40%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
485.51K
2.37%
-71.73K
-12.87%
Sep 30, 2025
Nuveen LLC
478.02K
2.34%
+19.45K
+4.24%
Sep 30, 2025
Fidelity Management & Research Company LLC
413.62K
2.02%
+354.02K
+594.03%
Sep 30, 2025
Castleknight Management LP
399.78K
1.96%
-131.56K
-24.76%
Sep 30, 2025
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
ETF āļāļĩāđāđāļāļĩāđāļĒāļ§āļāđāļāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāđāļŠāļēāļĢāđāļāļĩāđ 6 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāđāļŠāļēāļĢāđāļāļĩāđ 6 āļ.āļ.
āļāļ·āđāļ
āļŠāļąāļāļŠāđāļ§āļ
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
AAM Sawgrass US Small Cap Quality Growth ETF
āļŠāļąāļāļŠāđāļ§āļ2.49%
State Street SPDR S&P Pharmaceuticals ETF
āļŠāļąāļāļŠāđāļ§āļ1.19%
Innovator IBD 50 Fund ETF
āļŠāļąāļāļŠāđāļ§āļ1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.06%
Inspire Fidelis Multi Factor ETF
āļŠāļąāļāļŠāđāļ§āļ1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
āļŠāļąāļāļŠāđāļ§āļ1.02%
Lattice Hartford Multifactor Small Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ0.76%
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļāļŠāđāļ§āļ0.61%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ0.52%
āđāļāļīāļāļāļąāļāļāļĨ
îāļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
97.20M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
āļ§āļąāļāļāļĩāđ
āđāļāļīāļāļāļąāļāļāļĨ
āļ§āļąāļāļāļĩāđāļāļąāļāļāļķāļ
āļ§āļąāļāļāļĩāđāļāļģāļĢāļ°āđāļāļīāļ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļēāļĢāđāļāđāļāļŦāļļāđāļ
îāļ§āļąāļāļāļĩāđ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
āļ§āļąāļāļāļĩāđ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
āļāļģāļāļēāļĄāļāļĩāđāļāļāļāđāļāļĒ
āđāļāļĢāļāļ·āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Phibro Animal Health Corp?
îāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Phibro Animal Health Corp āđāļāđāđāļāđ:
BlackRock Institutional Trust Company, N.A. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 2.92M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 14.28% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
The Vanguard Group, Inc. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 1.52M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 7.44% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
State Street Investment Management (US) āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 894.04K āļŦāļļāđāļ āļāļīāļāđāļāđāļ 4.37% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Acadian Asset Management LLC āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 785.82K āļŦāļļāđāļ āļāļīāļāđāļāđāļ 3.84% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Renaissance Technologies LLC āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 555.20K āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.72% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
BlackRock Institutional Trust Company, N.A. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 2.92M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 14.28% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
The Vanguard Group, Inc. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 1.52M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 7.44% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
State Street Investment Management (US) āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 894.04K āļŦāļļāđāļ āļāļīāļāđāļāđāļ 4.37% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Acadian Asset Management LLC āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 785.82K āļŦāļļāđāļ āļāļīāļāđāļāđāļ 3.84% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Renaissance Technologies LLC āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 555.20K āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.72% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŠāļēāļĄāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Phibro Animal Health Corp āļāļ·āļāļāļ°āđāļĢ?
îāļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŠāļēāļĄāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Phibro Animal Health Corp āđāļāđāđāļāđ
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
āļĄāļĩāļāļĩāđāļŠāļāļēāļāļąāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ Phibro Animal Health Corp (PAHC)?
îāļ āļ§āļąāļāļāļĩāđ 2025Q4 āļĄāļĩāļŠāļāļēāļāļąāļāļāļģāļāļ§āļ 421 āđāļŦāđāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ Phibro Animal Health Corp āđāļāļĒāļĄāļĩāļĄāļđāļĨāļāđāļēāļĢāļ§āļĄāļāļĢāļ°āļĄāļēāļ 20.39M āļāļīāļāđāļāđāļ 99.73% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ āđāļĄāļ·āđāļāđāļāļĩāļĒāļāļāļąāļāļ§āļąāļāļāļĩāđ 2025Q3 āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļāđāļāđāđāļāļīāđāļĄāļāļķāđāļ -7.02%
āđāļŦāļĨāđāļāļĢāļēāļĒāđāļāđāļŦāļĨāļąāļāļāļāļ Phibro Animal Health Corp āļāļ·āļāļāļ°āđāļĢ?
îāđāļĄāļ·āđāļāļ§āļąāļāļāļĩāđ FY2026Q1 āļāļļāļĢāļāļīāļāļāđāļēāļ MFAs and Other āļŠāļĢāđāļēāļāļĢāļēāļĒāđāļāđāļŠāļđāļāļŠāļļāļāđāļŦāđāļāļąāļ Phibro Animal Health Corp āļāļīāļāđāļāđāļāļĄāļđāļĨāļāđāļē 195.20M āđāļĨāļ°āļāļīāļāđāļāđāļ 53.64% āļāļāļāļĢāļēāļĒāđāļāđāļĢāļ§āļĄ
